The current status on lung cancer radiotherapy is: 1) chemoradiotherapy is the standard treatment for advanced lung cancer; 2) neoadjuvant/adjuvant radiotherapy prolongs the OS in selected patients; 3) SBRT is not inferior to surgery for early-stage NSCLC; 4) PCI is necessary in patients with LS-SCLC; 5) selected patients with metastatic lung cancer benefit from radiotherapy; and 6) CCRT plus anti-PD-1 or anti-PD-L1 antibodies can further improve the prognosis of patients with advanced lung cancer. Here, CD274 is linked to lung cancer.